Vinorelbine softgel capsules are a pharmaceutical product formulated for use in oncology, specifically indicated for the treatment of non-small cell lung cancer and certain other malignancies. As a generic version of the active substance vinorelbine, this formulation offers an alternative for sourcing buyers in the pharmaceutical supply chain seeking established chemotherapeutic agents. Softgel capsules provide a standardized oral dosage form, which is commonly utilized in clinical settings for its ease of administration compared to intravenous alternatives.
Manufactured by Lotus Pharmaceutical, a company founded in 1966 and based in Tashkent, Uzbekistan, this product is listed under the pharmaceutical products category. The manufacturer’s long-standing presence in the industry may be of interest to international buyers evaluating supply sources in Central Asia. This catalog entry reflects a generic oncology medication suitable for procurement by distributors, hospitals, and healthcare institutions involved in cancer treatment protocols.